These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 482695

  • 1. [Growth hormone secretion induced by L-Dopa and a dopa decarboxylase inhibitor blocked by free fatty acids].
    Casanueva F, Villanueva L, Peñalva A, Barrionuevo JA, Vila T, Cabezas-Cerrato J.
    Rev Clin Esp; 1979 May 15; 153(3):221-4. PubMed ID: 482695
    [No Abstract] [Full Text] [Related]

  • 2. [Free fatty acids (FFA) blocking growth hormone secretion induced by L-Dopa].
    Casanueva F, Villanueva L, Peñalva A, Rodríguez R, Vila T, Cabezas-Cerrato J.
    Rev Clin Esp; 1979 May 15; 153(3):217-20. PubMed ID: 482694
    [No Abstract] [Full Text] [Related]

  • 3. [Amantadine potentiation of G.H. relase evoked by L-dopa and its inhibition by nonesterified fatty acids].
    Cabezas-Cerrato J, Casanueva Freijo F, Villanueva Aranguren L, Avila C, Fernández-Cruz A.
    Rev Clin Esp; 1977 May 15; 145(3):165-8. PubMed ID: 866739
    [No Abstract] [Full Text] [Related]

  • 4. [Attempt at potentiation of the action of L-dopa on the secretion of growth hormone by benserazide, disulfiram and propranolol].
    Rochiccioli P, Enjaume P, Dutau G, Ribot C, Augier D.
    Arch Fr Pediatr; 1976 Jan 15; 33(1):55-66. PubMed ID: 985031
    [Abstract] [Full Text] [Related]

  • 5. Stimulatory effect of the dopa-decarboxylase inhibitor Ro 4-4602 on prolactin release; inhibition by l-dopa, metergoline, methysergide and 2-Br-alpha-ergocryptine.
    Pontiroli AE, Castegnaro E, Vettaro MP, Viberti GC, Pozza G.
    Acta Endocrinol (Copenh); 1977 Jan 15; 84(1):36-44. PubMed ID: 318788
    [No Abstract] [Full Text] [Related]

  • 6. The effect of L-dopa and an inhibitor of peripheral decarboxylation on glucose metabolism in brain.
    Tyce GM.
    J Neurochem; 1976 Dec 15; 27(6):1397-403. PubMed ID: 1003214
    [No Abstract] [Full Text] [Related]

  • 7. [Dopaminergic control of the diencephalo-pituitary axis for somatotropin secretion].
    Cavagnini F, Pontiroli AE, Raggi U, Peracchi M, Malinverni A.
    Folia Endocrinol; 1973 Dec 15; 26(6):483-9. PubMed ID: 4801258
    [No Abstract] [Full Text] [Related]

  • 8. [Effect of VB6 on L-DOPA decarboxylase activity in the organs of rats given peripheral L-DOPA decarboxylase inhibitors (author's transl)].
    Yoshimine N, Kuzuya F, Mori K, Sakamoto N.
    Nihon Ronen Igakkai Zasshi; 1978 Nov 15; 15(6):566-73. PubMed ID: 732010
    [No Abstract] [Full Text] [Related]

  • 9. The effect of L-dopa with and without decarboxylase inhibitor on growth hormone secretion in children with short stature.
    Fevang FO, Stoa RF, Thorsen T, Aarskog D.
    Acta Paediatr Scand; 1977 Jan 15; 66(1):81-4. PubMed ID: 831384
    [Abstract] [Full Text] [Related]

  • 10. [Action of a peripheral inhibitor of dopa-decarboxylase on the inhibition by L-DOPA of the hypothalamo-hypophyseo-adrenocortical system in man].
    Balestreri R, Bertolini S, Elicio N, Costa S.
    Boll Soc Ital Biol Sper; 1974 Jul 30; 50(12):832-7. PubMed ID: 4447697
    [No Abstract] [Full Text] [Related]

  • 11. A comparison of the effects of decarboxylase inhibitors on L-dopa-induced circling behavior and the conversion of dopa to dopamine in the brain.
    Goodale DB, Moore KE.
    Life Sci; 1976 Sep 01; 19(5):701-6. PubMed ID: 957902
    [No Abstract] [Full Text] [Related]

  • 12. [Effects of adrenergic blocking agents on HGH secretion after administration of L-Dopa].
    Ragonese F, Melluso K, Campisi R, Carducci Artenisio A.
    Boll Soc Ital Biol Sper; 1975 Dec 30; 51(24):1969-74. PubMed ID: 1231881
    [No Abstract] [Full Text] [Related]

  • 13. [Effect of carbidopa and L-dopa combination on the secretion of growth hormone in normal subjects and in patients with Parkinsonism].
    Nurzia A, Vacca U, Pirro R, Cerone G.
    Clin Ter; 1975 Aug 15; 74(3):265-70. PubMed ID: 1227747
    [No Abstract] [Full Text] [Related]

  • 14. In vivo assessment of decarboxylase inhibition or potentiation: urinary dopamine and L-dopa output after L-dopa administration.
    Johnson RD, Ruthven CR, Goodwin BL, Sandler M.
    J Neural Transm; 1976 Aug 15; 38(3-4):181-91. PubMed ID: 956809
    [Abstract] [Full Text] [Related]

  • 15. Reduced growth hormone response to L-dopa and pyridostigmine in obesity.
    Lee EJ, Kim KR, Lee KM, Lim SK, Lee HC, Lee JH, Lee DJ, Huh KB.
    Int J Obes Relat Metab Disord; 1994 Jul 15; 18(7):465-8. PubMed ID: 7920871
    [Abstract] [Full Text] [Related]

  • 16. Locomotor response to L-DOPA in reserpine-treated rats following central inhibition of aromatic L-amino acid decarboxylase: further evidence for non-dopaminergic actions of L-DOPA and its metabolites.
    Alachkar A, Brotchie JM, Jones OT.
    Neurosci Res; 2010 Sep 15; 68(1):44-50. PubMed ID: 20542064
    [Abstract] [Full Text] [Related]

  • 17. Propranolol enhancement of L-DOPA induced growth hormone stimulation.
    Camanni F, Massara F, Molinatti GM.
    Biomedicine; 1974 Jun 10; 21(6):241-3. PubMed ID: 4441586
    [No Abstract] [Full Text] [Related]

  • 18. [Inhibition by nonesterified fatty acids of growth hormone secretion induced by intravenous arginine infusion].
    Cabezas-Cerrato J, Casanueva Freijo F, Villanueva Aranguren L, Vila T, Fernández-Cruz A.
    Rev Clin Esp; 1977 Feb 15; 144(3):201-5. PubMed ID: 841147
    [No Abstract] [Full Text] [Related]

  • 19. Effects of a decarboxylase inhibitor on the Dopa and 5-HTP induced changes in the locomotor-like discharge pattern of rabbit hind limb nerves.
    Viala D, Buser P.
    Psychopharmacologia; 1974 Feb 15; 40(3):225-33. PubMed ID: 4548539
    [No Abstract] [Full Text] [Related]

  • 20. L-Dopa inhibits prolactin secretion in proestrous rats.
    Wiggins JF, Fernstrom JD.
    Endocrinology; 1977 Aug 15; 101(2):469-74. PubMed ID: 560295
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.